PATENT CLAIM ANALYSIS

Application Number: 16032319
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "121000"]

Abstract:
The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

Claim (Index 2):
The non-naturally occurring ketoreductase polypeptide of  claim 1 , wherein the amino acid sequence of said non-naturally occurring ketoreductase polypeptide further comprises one or more of the features selected from:\n the residue at position X40 is R; the residue at position X93 is A and the residue at position X94 is T; the residue at position X93 is A and the residue at position X94 is P; the residue at position X93 is A and the residue at position X94 is S; or the residue at position X93 is I and the residue at position X94 is S.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.19048
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15478466', '15179503', '14692964', '13695856', '14790311']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7158631829379374
- 35 USC 102 Novelty (BERT): 0.6882948597325126
- Combined Prediction Score: 0.7131063506173949
- Mean Citation Score: 624.344638
- Max Citation Score: 716.4999
- Similarity Product: 687.4703473599315

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test